Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MØLLER, H. J.
Right arrow Articles by POULSEN, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MØLLER, H. J.
Right arrow Articles by POULSEN, J. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 British Society for Rheumatology

research-article

THE EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF THE HUMAN CARTILAGE LARGE AGGREGATING PROTEOGLYCAN, AGGRECAN: INCREASED SERUM CONCENTRATION IN RHEUMATOID ARTHRITIS

H. J. MØLLER*, T. INGEMANN-HANSEN{dagger} and J. H. POULSEN*

*Department of Clinical Chemistry K. H. University Hospital DK-8000, Aarhus C, Denmark
{dagger}Department of Rheumatology, K. H. University Hospital DK-8000, Aarhus C, Denmark

The large aggregating proteoglycan from human cartilage, aggrecan, has recently been shown to possess an immunologically detectable domain with close homology to epidermal growth factor (EGF), that is variably expressed by alternative mRNA splicing. Using a competitive ELISA we detected this domain in sera from both patients with RA and normal controls. The EGF-like domain could only be detected after digestion of sera with chondroitinase ABC, which demonstrates its proteoglycan origin. The concentration of the aggrecan EGF-like domain was considerably elevated in sera from patients with RA as compared to the control sera (P<0.001), and the concentration of the domain increased with age in both the patient (r = 0.58, P<0.05) and the control (r = 0.66, P0.01) group. These results demonstrate that the EGF-like domain of aggrecan could be of value as a marker of RA.

KEY WORDS: Arthritis, ELISA, Epidermal growth factor, Keratan, Proteoglycan, Serum levels


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.